A detailed history of Citigroup Inc transactions in Inari Medical, Inc. stock. As of the latest transaction made, Citigroup Inc holds 65,482 shares of NARI stock, worth $3.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,482
Previous 37,563 74.33%
Holding current value
$3.63 Million
Previous $1.81 Million 49.28%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.68 - $58.62 $1.14 Million - $1.64 Million
27,919 Added 74.33%
65,482 $2.7 Million
Q2 2024

Aug 12, 2024

BUY
$37.11 - $50.69 $186,143 - $254,261
5,016 Added 15.41%
37,563 $1.81 Million
Q1 2024

May 10, 2024

SELL
$40.65 - $65.76 $329,752 - $533,445
-8,112 Reduced 19.95%
32,547 $1.56 Million
Q4 2023

Feb 09, 2024

BUY
$48.3 - $68.06 $150,599 - $212,211
3,118 Added 8.31%
40,659 $2.64 Million
Q3 2023

Nov 09, 2023

BUY
$54.2 - $71.67 $975,708 - $1.29 Million
18,002 Added 92.13%
37,541 $2.46 Million
Q2 2023

Aug 10, 2023

BUY
$56.23 - $71.17 $763,153 - $965,919
13,572 Added 227.45%
19,539 $1.14 Million
Q1 2023

May 11, 2023

SELL
$53.43 - $68.12 $73,840 - $94,141
-1,382 Reduced 18.81%
5,967 $368,000
Q4 2022

Feb 09, 2023

SELL
$61.23 - $83.62 $337,009 - $460,244
-5,504 Reduced 42.82%
7,349 $467,000
Q3 2022

Nov 10, 2022

BUY
$65.58 - $84.69 $370,199 - $478,075
5,645 Added 78.32%
12,853 $933,000
Q2 2022

Aug 10, 2022

BUY
$52.13 - $93.81 $77,621 - $139,683
1,489 Added 26.04%
7,208 $491,000
Q1 2022

May 12, 2022

SELL
$64.92 - $99.47 $472,422 - $723,843
-7,277 Reduced 55.99%
5,719 $518,000
Q4 2021

Feb 10, 2022

BUY
$76.51 - $93.96 $366,865 - $450,538
4,795 Added 58.47%
12,996 $1.19 Million
Q3 2021

Nov 10, 2021

BUY
$71.29 - $95.99 $584,649 - $787,213
8,201 New
8,201 $665,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.